Bahrt Kenneth 4
4 · Outlook Therapeutics, Inc. · Filed Feb 19, 2019
Insider Transaction Report
Form 4
Bahrt Kenneth
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-02-19+600,000→ 600,000 totalExercise: $1.32Exp: 2029-02-19→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest in four equal installments beginning on February 19, 2020 such that the option shall be vested in full on February 19, 2023, subject to the Reporting Person providing continuous service to the Issuer on each such date. Vesting may be accelerated in the event of (a) a change in control as defined in the Issuer's 2015 Equity Incentive Plan and (b) the achievement of certain pre-defined corporate objectives, in each case subject to the Reporting Person providing continuous service to the Issuer through such event.